{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T12:42:19Z","timestamp":1787920939248,"version":"build-2784847793"},"reference-count":15,"publisher":"American Society of Hematology","issue":"12","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2004,6,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>There were 50 consecutive idiopathic thrombocytopenic purpura (ITP) adult patients (platelet count &amp;lt; 100 \u00d7 109\/L) grouped according to positivity or negativity of a solid-phase modified antigen capture enzyme-linked immunosorbent assay (ELISA) test (MACE) against glycoprotein IIb\/IIIa (GPIIb\/IIIa), Ib\/IX, and IIa\/IIIa. Observation started on the day of MACE assay and lasted at least 6 months. Clinical worsening was defined as the need for starting or modifying therapy because of thrombocytopenia lower than 20 \u00d7 109\/L or patient admission due to bleeding symptoms. MACE-positive patients had a higher probability of clinical worsening than MACE-negatives (P &amp;lt; .004). The proportion of patients worsening was 18 (72%) of 25 among MACE-positives and 8 (32%) of 25 among MACE-negatives. The median time to clinical worsening was 2.1 months for MACE-positive patients and 27.7 months for MACE-negatives. The assay of specific platelet autoantibodies may be a useful prognostic tool for the clinical course of ITP. (Blood. 2004;103:4562-4564)<\/jats:p>","DOI":"10.1182\/blood-2003-09-3352","type":"journal-article","created":{"date-parts":[[2004,2,23]],"date-time":"2004-02-23T20:49:31Z","timestamp":1077569371000},"page":"4562-4564","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":43,"title":["Platelet-associated autoantibodies as detected by a solid-phase modified antigen capture ELISA test (MACE) are a useful prognostic factor in idiopathic thrombocytopenic purpura"],"prefix":"10.1182","volume":"103","author":[{"given":"Fabrizio","family":"Fabris","sequence":"first","affiliation":[{"name":"From the Department of Medical and Surgical Sciences, University of Padua Medical School, Padova, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"Scandellari","sequence":"additional","affiliation":[{"name":"From the Department of Medical and Surgical Sciences, University of Padua Medical School, Padova, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Ruzzon","sequence":"additional","affiliation":[{"name":"From the Department of Medical and Surgical Sciences, University of Padua Medical School, Padova, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Luigia","family":"Randi","sequence":"additional","affiliation":[{"name":"From the Department of Medical and Surgical Sciences, University of Padua Medical School, Padova, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Luzzatto","sequence":"additional","affiliation":[{"name":"From the Department of Medical and Surgical Sciences, University of Padua Medical School, Padova, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Girolami","sequence":"additional","affiliation":[{"name":"From the Department of Medical and Surgical Sciences, University of Padua Medical School, Padova, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020021217474769000_REF1","doi-asserted-by":"crossref","unstructured":"George JN, Woolf SH, Raskob GE, et al. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood. 1996;88: 3-40.","DOI":"10.1182\/blood.V88.1.3.3"},{"key":"2020021217474769000_REF2","doi-asserted-by":"crossref","unstructured":"Brighton TA, Evans S, Castaldi PA, Chesterman CN, Chong BH. Prospective evaluation of the clinical usefulness of an antigen-specific assay (MAIPA) in idiopathic thrombocytopenic purpura and other immune thrombocytopenias. Blood. 1996;88: 194-201.","DOI":"10.1182\/blood.V88.1.194.194"},{"key":"2020021217474769000_REF3","doi-asserted-by":"crossref","unstructured":"Warner MN, Moore JC, Warkentin TE, Santos AV, Kelton JG. A prospective study of protein-specific assays used to investigate idiopathic thrombocytopenic purpura. Br J Haematol. 1999;104: 442-447.","DOI":"10.1046\/j.1365-2141.1999.01218.x"},{"key":"2020021217474769000_REF4","doi-asserted-by":"crossref","unstructured":"McMillan R, Wang L, Tani P. Prospective evaluation of the immunobead assay for the diagnosis of adult chronic immune thrombocytopenic purpura (ITP). J Thromb Haemost. 2003;1: 485-491.","DOI":"10.1046\/j.1538-7836.2003.00091.x"},{"key":"2020021217474769000_REF5","doi-asserted-by":"crossref","unstructured":"Berchtold P, Wenger M. Autoantibodies against platelet glycoproteins in autoimmune thrombocytopenic purpura: their clinical significance and response to treatment. Blood. 1993;81: 1246-1250.","DOI":"10.1182\/blood.V81.5.1246.1246"},{"key":"2020021217474769000_REF6","doi-asserted-by":"crossref","unstructured":"Hou M, Stockelberg D, Kutti J, Wadenvik H. Antibodies against GPIb\/IX, GPIIb\/IIIa, and other platelet antigens in chronic idiopathic thrombocytopenic purpura. Eur J Haematol. 1995;55: 307-314.","DOI":"10.1111\/j.1600-0609.1995.tb00702.x"},{"key":"2020021217474769000_REF7","doi-asserted-by":"crossref","unstructured":"Nomura S, Yanabu M, Soga T, et al. Analysis of idiopathic thrombocytopenic purpura patients with antiglycoprotein IIb\/IIIa or Ib autoantibodies. Acta Haematol. 1991;86: 25-30.","DOI":"10.1159\/000204794"},{"key":"2020021217474769000_REF8","doi-asserted-by":"crossref","unstructured":"Fujisawa K, Tani P, Piro L, Mc Millan R. The effect of therapy on platelet-associated autoantibody in chronic immune thrombocytopenic purpura. Blood. 1993;81: 2872-2877.","DOI":"10.1182\/blood.V81.11.2872.2872"},{"key":"2020021217474769000_REF9","doi-asserted-by":"crossref","unstructured":"Kayser W, Mueller-Eckhardt C, Mueller-Eckhardt G. The value of platelet-associated IgG in predicting the efficacy of splenectomy in autoimmune thrombocytopenia. Scand J Haematol. 1983;30: 30-35.","DOI":"10.1111\/j.1600-0609.1983.tb00631.x"},{"key":"2020021217474769000_REF10","doi-asserted-by":"crossref","unstructured":"Kiefel V, Santoso S, Weisheit M, Mueller-Eckhardt C. Monoclonal antibody-specific immobilization of platelet antigens (MAIPA): a new tool for the identification of platelet-reactive antibodies. Blood. 1987;70: 1722-1726.","DOI":"10.1182\/blood.V70.6.1722.1722"},{"key":"2020021217474769000_REF11","unstructured":"Fabris F, Scandellari R, Randi ML, Carraro G, Luzzatto G, Girolami A. Attempt to improve the diagnosis of immune thrombocytopenia by combined use of two different platelet autoantibodies assays (PAIgG and MACE). Haematologica. 2002;87: 1046-1052."},{"key":"2020021217474769000_REF12","doi-asserted-by":"crossref","unstructured":"Portielje JE, Westendorp RG, Kluin-Nelemans HC, Brand A. Morbidity and mortality in adults with idiopathic thrombocytopenic purpura. Blood. 2001;97: 2549-2554.","DOI":"10.1182\/blood.V97.9.2549"},{"key":"2020021217474769000_REF13","doi-asserted-by":"crossref","unstructured":"Kiefel V, Santoso S, Kaufmann E, Mueller-Eckhardt C. Autoantibodies against glycoprotein Ib\/IX: a frequent finding in autoimmune thrombocytopenic purpura. Br J Haematol. 1991;79: 256-262.","DOI":"10.1111\/j.1365-2141.1991.tb04530.x"},{"key":"2020021217474769000_REF14","doi-asserted-by":"crossref","unstructured":"Kosugi S, Tomiyama Y, Shiraga M, et al. Platelet-associated anti-glycoprotein (GP) IIb-IIIa auto-antibodies in chronic immune thrombocytopenic purpura mainly recognize cation-dependent conformations: comparisons with epitopes of serum autoantibodies. Thromb Haemost. 1996;75: 339-345.","DOI":"10.1055\/s-0038-1650271"},{"key":"2020021217474769000_REF15","doi-asserted-by":"crossref","unstructured":"Mehta YS, Pathare AV, Badakere SS, Ghosh K, Mohanty D. Influence of auto-antibody specificities on the clinical course in patients with chronic and acute ITP. Platelets. 2000;11: 94-98.","DOI":"10.1080\/09537100075706"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/103\/12\/4562\/1697921\/zh801204004562.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/103\/12\/4562\/1697921\/zh801204004562.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,12]],"date-time":"2020-02-12T18:45:44Z","timestamp":1581533144000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/103\/12\/4562\/131367\/Plateletassociated-autoantibodies-as-detected-by-a"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,6,15]]},"references-count":15,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2004,6,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2003-09-3352","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,6,15]]}}}